BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27248461)

  • 1. Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects.
    Busk TM; Bendtsen F; Møller S
    Expert Rev Gastroenterol Hepatol; 2016 Oct; 10(10):1153-1161. PubMed ID: 27248461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document.
    Angeli P; Garcia-Tsao G; Nadim MK; Parikh CR
    J Hepatol; 2019 Oct; 71(4):811-822. PubMed ID: 31302175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatorenal syndrome].
    Ben Chaabane N; Melki W; Hellara O; Safer L; Bdioui F; Saffar H
    Tunis Med; 2011 Dec; 89(12):885-90. PubMed ID: 22198887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review for the Practicing Clinician: Hepatorenal Syndrome, a Form of Acute Kidney Injury, in Patients with Cirrhosis.
    Chaney A
    Clin Exp Gastroenterol; 2021; 14():385-396. PubMed ID: 34675586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hepatorenal syndrome.
    Dundar HZ; Yılmazlar T
    World J Nephrol; 2015 May; 4(2):277-86. PubMed ID: 25949942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.
    Salerno F; Gerbes A; Ginès P; Wong F; Arroyo V
    Postgrad Med J; 2008 Dec; 84(998):662-70. PubMed ID: 19201943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatorenal syndrome].
    Mijac D; Kezić A; Stojimirović B
    Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatorenal Syndrome Type 1: Current Challenges And Future Prospects.
    Facciorusso A
    Ther Clin Risk Manag; 2019; 15():1383-1391. PubMed ID: 31819465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatorenal syndrome.
    Guevara M; Rodés J
    Int J Biochem Cell Biol; 2005 Jan; 37(1):22-6. PubMed ID: 15381144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and treatment of hepatorenal syndrome.
    Arroyo V; Fernandez J; Ginès P
    Semin Liver Dis; 2008 Feb; 28(1):81-95. PubMed ID: 18293279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute Kidney Injury in Cirrhotic Patients with Portal Hypertension].
    Kim SM; Song IH
    Korean J Gastroenterol; 2016 Nov; 68(5):237-244. PubMed ID: 27871159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies.
    Meltzer J; Brentjens TE
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):139-44. PubMed ID: 20124895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatorenal syndrome: the clinical impact of vasoactive therapy.
    Colle I; Laterre PF
    Expert Rev Gastroenterol Hepatol; 2018 Feb; 12(2):173-188. PubMed ID: 29258378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis.
    Bernardi M; Moreau R; Angeli P; Schnabl B; Arroyo V
    J Hepatol; 2015 Nov; 63(5):1272-84. PubMed ID: 26192220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatorenal syndrome in patients with liver cirrhosis].
    Zaza S; Bonny O; Liaudet L
    Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatorenal syndrome: a critical update.
    Wadei HM
    Semin Respir Crit Care Med; 2012 Feb; 33(1):55-69. PubMed ID: 22447261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Egerod Israelsen M; Gluud LL; Krag A
    J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?
    Gülberg V; Gerbes AL
    Z Gastroenterol; 2002 Sep; 40(9):823-6. PubMed ID: 12215953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.
    Møller S; Krag A; Bendtsen F
    Liver Int; 2014 Sep; 34(8):1153-63. PubMed ID: 24673771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.